These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2154815)

  • 21. The delta receptor is involved in sufentanil-induced respiratory depression--opioid subreceptors mediate different effects.
    Freye E; Latasch L; Portoghese PS
    Eur J Anaesthesiol; 1992 Nov; 9(6):457-62. PubMed ID: 1330549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.
    Portoghese PS; Larson DL; Jiang JB; Caruso TP; Takemori AE
    J Med Chem; 1979 Feb; 22(2):168-73. PubMed ID: 218009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid analgesia in the mouse: evidence for multiple receptors using beta-FNA.
    Sánchez-Blázquez P; Garzón J
    NIDA Res Monogr; 1986; 75():465-8. PubMed ID: 2828993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid antagonists: structure activity relationships.
    Zimmerman DM; Leander JD
    NIDA Res Monogr; 1990; 96():50-60. PubMed ID: 2172827
    [No Abstract]   [Full Text] [Related]  

  • 26. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
    Malmberg AB; Yaksh TL
    J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic 14-hydroxymorphinan narcotic antagonists.
    Pachter IJ
    Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
    [No Abstract]   [Full Text] [Related]  

  • 28. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroanatomical correlates of morphine dependence.
    Wei E; Loh HH; Way EL
    Science; 1972 Aug; 177(4049):616-7. PubMed ID: 4558902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouse.
    Ayres EA; Parkhurst DN; Fang S; Kramer TH; Hruby VJ; Burks TF
    Proc West Pharmacol Soc; 1991; 34():477-84. PubMed ID: 1788334
    [No Abstract]   [Full Text] [Related]  

  • 32. Naloxone enhancement of memory processes: effects of other opiate antagonists.
    Gallagher M
    Behav Neural Biol; 1982 Aug; 35(4):375-82. PubMed ID: 6299265
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
    Sofuoglu M; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of opiate antagonists and their quaternary analogues on nucleus accumbens self-stimulation.
    Trujillo KA; Belluzzi JD; Stein L
    Behav Brain Res; 1989 Jun; 33(2):181-8. PubMed ID: 2548531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of morphine by long acting narcotic antagonists.
    Dykstra LA; McMillan DE; Harris LS
    Psychopharmacologia; 1974; 39(2):151-62. PubMed ID: 4476081
    [No Abstract]   [Full Text] [Related]  

  • 38. Mu and delta opioid receptor interactions in a rat model of drug induced seizures.
    Tortella FC; Holaday JW
    Proc West Pharmacol Soc; 1984; 27():435-7. PubMed ID: 6093137
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 40. Physical dependence on morphine using the mu receptor deficient CXBK mouse.
    Suzuki T; Misawa M
    Prog Clin Biol Res; 1990; 328():519-22. PubMed ID: 2154813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.